Changes In Your Gut
Ozempic, Wegovy, Zepbound, Mounjaro — these medications are changing lives. But for many patients, they also change your gut. Here’s the science behind why, and what’s actually happening in your digestive tract.
-
80%
of GLP-1 patients show delayed gastric emptying in clinical studies
-
44%
have measurably delayed whole-gut transit time on testing
-
#1
GI complaint reported by patients on semaglutide
What GLP-1 Medications Actually Do to Your Gut
GLP-1 receptor agonists work by mimicking a natural gut hormone called glucagon-like peptide-1. Activating these receptors slows how quickly food moves through your digestive tract — which is partly the point. Slower gastric emptying helps you feel full longer and blunts post-meal blood sugar spikes.
But GLP-1 receptors aren’t only in the stomach. They’re distributed throughout the entire gastrointestinal tract, including the small intestine and colon. When GLP-1 drugs activate these receptors systemically, the slowdown cascades through the whole gut — not just the stomach.
For most patients, this effect persists for the entire duration of treatment, not just during initial adjustment.
The Mechanisms Behind GLP-1-Related Constipation
-
Myenteric neuron inhibition
GLP-1 receptors sit in the enteric nervous system — your gut’s own neural network. Activation suppresses the myenteric neurons that coordinate peristalsis: the rhythmic contractions that push food and waste through your intestines.
-
Disrupted migrating motor complex
Between meals, your gut runs a “housekeeping” contraction cycle called the migrating motor complex (MMC). GLP-1 drugs reduce MMC activity — disrupting the wave that normally sweeps residue toward the colon during fasting.
-
Delayed gastric emptying
GLP-1 slows how quickly your stomach empties into the small intestine. A 2025 Cleveland Clinic study found 80% of patients on GLP-1 agonists had measurably delayed gastric emptying — a slowdown that ripples down the entire tract.
-
Excess colonic water absorption
The longer stool sits in the colon, the more water the colon extracts from it. A stool that might have been soft and easy to pass becomes hard and dry — the hallmark of GLP-1-related constipation.
What Slows Down, And Where
-
1. Stomach
Emptying slows. Food sits longer before passing on.
-
2. Small intestine
MMC disrupted. Transit slows, especially on semaglutide.
-
3. Colon
More time = more water absorbed. Stool hardens.
-
! Result
Hard, infrequent stools. Bloating. Straining.
Symptoms to Watch For
GLP-1 constipation has a recognizable pattern. Common signs include:
- Fewer than 3 bowel movements per week
- Hard or lumpy stools (Bristol types 1–2)
- Straining or incomplete emptying
- Abdominal bloating and pressure
- Nausea that worsens with food
- Feeling backed up even after going
These symptoms won’t resolve on their own while you’re on the medication. Chronic constipation can worsen bloating, increase GI pressure, and undermine the benefits you’re working toward.
Frequently asked questions
-
GLP-1 receptor agonists slow gut motility through three mechanisms: inhibition of myenteric neurons that coordinate peristalsis, disruption of the migrating motor complex (MMC), and delayed gastric emptying. The result is slower whole-gut transit, giving the colon more time to absorb water from stool — making it hard, dry, and difficult to pass.
-
For most patients, the gut-slowing effect persists for the full duration of treatment — it’s tied to ongoing receptor activation, not a temporary adjustment response. Daily digestive support is typically the most effective approach.
-
All GLP-1 receptor agonists can slow gut motility — including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity). Research suggests semaglutide at higher doses may have the strongest effect on whole-gut transit time.
Now that you understand why it happens — here’s what to do about it.
Go is a physician-formulated, non-habit forming supplement designed for exactly this kind of constipation.